Read or download the full Economic Impact Assessment report Read more
LifeArc: £3m fund to accelerate development of new CF therapies
Published on 16 Mar 2023
GSK announces positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine candidate
Published on 14 Mar 2023
Thermo Fisher Scientific simplifies trace elemental analysis in environmental, food, pharmaceutical and industrial testing labs
Published on 8 Mar 2023
Cytiva and TerraCycle expand first-of-its kind recycling program
Published on 8 Mar 2023
Stevenage innovation and technology centre creates stem pipeline for the local community
Published on 7 Mar 2023
Revolo Biotherapeutics presents new data demonstrating long-lasting effect of ‘1104 in a food allergy model at the 2023 AAAAI annual meeting
Published on 6 Mar 2023
SBC launches 8-week accelerator programme
Published on 22 Feb 2023
LifeArc Ventures invests in Maxion Therapeutics
Published on 15 Feb 2023
Landmark New England Journal of Medicine publication reinforces potential of GSK’s respiratory syncytial virus older adult vaccine candidate
Published on 15 Feb 2023
First of its kind to receive ACT environmental impact score
Published on 15 Feb 2023
Graduate student available for short-term summer placement
Published on 13 Feb 2023
Freeline announces closing of sale of its CMC-focused German subsidiary
Published on 10 Feb 2023
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva’s latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies
Published on 10 Feb 2023
Thermo Fisher Scientific launches TrueMark STI select panel
Published on 8 Feb 2023
SBC joins round table discussion on the developmement of life sciences in Stevenage
Published on 7 Feb 2023
Hertfordshire Local Skills Improvement Plan Survey: Life sciences focus group
Published on 7 Feb 2023
Genevation Ltd joins SBC's Lab Hotel
Published on 6 Feb 2023
Sally Ann Forsyth joins panel at Eastern Powerhouse's inaugural conference
Published on 6 Feb 2023
GSK announces results from 17-year retrospective study on US clinical trial diversity
Published on 6 Feb 2023
Thermo Fisher Scientific collaborates to introduce fully automated cell line automation platform
Published on 6 Feb 2023
LifeArc Ventures: Strong performance in 2022 & sustained investment in innovation
Published on 1 Feb 2023

Copyright © 2023 Stevenage Bioscience Catalyst

Designed and built by Onespacemedia

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.